| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |